Dr. Li is the Co-Founder and Managing Partner of LYZZ Capital. He has over 20 years of professional experience in biomedical sciences, healthcare investment and entrepreneurship. Before co-founding LYZZ Capital, Dr. Li was a Partner at DT Capital, a Partner at HBM BioMed China, and an Associate at Toucan Capital in the US, all in the field of biotech investments. Dr. Li was also a co-founder of ClinChoice and Mojia Biotech. Dr. Li invested in a number of biomedical companies, including Neurelis, Qpex, Jumpcode, Onchilles, Wugen, Alpha Biopharma, Nuokang Biopharma, Cathay Biotech, Wuhan Hiteck Biopharma, Chipscreen, ClinChoice, among others.
Dr. Li received a Bachelor's degree from Nankai University, a doctorate degree in biological sciences from Indiana University and postdoctoral training from Stanford University.